xiaoyun lu
Jinan University
Guangzhou, China
Review Editor
Anti-Cancer Drugs
- Frontiers in Drug Discovery
- Anti-Cancer Drugs
- Editorial Board
Type at least 3 characters
122 editors
Shape the future of research in your field
Join the board
Editors
Review Editors
eduardo lópez-urrutia
National Autonomous University of Mexico
México City, Mexico
Review Editor
Anti-Cancer Drugs
rhanye mac guad
Universiti Malaysia Sabah
Kota Kinabalu, Malaysia
Review Editor
Anti-Cancer Drugs
miguel machuqueiro
University of Lisbon
Lisbon, Portugal
Review Editor
Anti-Cancer Drugs
rishabha malviya
School of Medical and Allied Sciences, Galgotias University
Greater Noida, India
Review Editor
Anti-Cancer Drugs
tamoghna mandal
BioClinicum, Karolinska University Hospital
Stockholm, Sweden
Review Editor
Anti-Cancer Drugs
vincenzo marsicano
University of L'Aquila
L'Aquila, Italy
Review Editor
Anti-Cancer Drugs
victor mayoral-varo
Faculty HM Hospitals of Health Sciences, Camilo José Cela University
Madrid, Spain
Review Editor
Anti-Cancer Drugs
zukile mbita
University of Limpopo
Sovenga, South Africa
Review Editor
Anti-Cancer Drugs
dhanalekshmi meenakshi
National University of Sciences and Technology (NUST)
Islamabad, Pakistan
Review Editor
Anti-Cancer Drugs
carmen mejía
Autonomous University of Queretaro
Santiago de Querétaro, Mexico
Review Editor
Anti-Cancer Drugs
jiaqi mi
Boehringer Ingelheim
Ingelheim, Germany
Review Editor
Anti-Cancer Drugs
hongming miao
Army Medical University
Chongqing, China
Review Editor
Anti-Cancer Drugs
jian min
Hubei University
Wuhan, China
Review Editor
Anti-Cancer Drugs
angelica montiel davalos
National Institute of Cancerology (INCAN)
Mexico City, Mexico
Review Editor
Anti-Cancer Drugs
andrew napper
Bristol Myers Squibb (United States)
New York, United States
Review Editor
Anti-Cancer Drugs